David A. Siegel Sangamo Therapeutics, Inc Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,428,255 shares of SGMO stock, worth $642,714. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,428,255

Previous 2,085,255 31.51%

Holding current value

$642,714

Previous $1.13 Million 15.1%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.42 - $1.38 $275,940 - $906,659	-657,000 Reduced 31.51%	1,428,255 $956,000
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $372,690 - $782,649	1,242,300 Added 147.37%	2,085,255 $1.13 Million
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.47 $97,382 - $246,813	-167,900 Reduced 16.61%	842,955 $505,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $1.74 $69,708 - $109,272	-62,800 Reduced 5.85%	1,010,855 $1.31 Million
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $199,366 - $440,767	-120,100 Reduced 10.06%	1,073,655 $1.89 Million

Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $302,207 - $553,137	109,100 Added 10.06%	1,193,755 $3.75 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $2.13 Million - $3.19 Million	498,900 Added 85.17%	1,084,655 $5.32 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $61,991 - $117,369	18,900 Added 3.33%	585,755 $2.43 Million
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $1.09 Million - $1.63 Million	-208,800 Reduced 26.92%	566,855 $3.29 Million
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $1.36 Million - $2.04 Million	-186,400 Reduced 19.38%	775,655 $5.82 Million
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $550,511 - $733,811	-61,100 Reduced 5.97%	962,055 $8.67 Million
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $3.89 Million - $4.83 Million	-382,200 Reduced 27.2%	1,023,155 $12.2 Million
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $90,304 - $141,515	-8,300 Reduced 0.59%	1,405,355 $17.6 Million
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $459,654 - $905,364	49,800 Added 3.65%	1,413,655 $22.1 Million
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $2.45 Million - $3.26 Million	261,200 Added 23.69%	1,363,855 $12.9 Million
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $4.98 Million - $9.49 Million	802,000 Added 266.75%	1,102,655 $9.88 Million
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $664,580 - $1.16 Million	131,600 Added 77.84%	300,655 $1.92 Million
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $1.36 Million - $1.98 Million	169,055 New	169,055 $1.42 Million
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $1.79 Million - $2.41 Million	-197,300 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $232,750 - $346,598	-26,600 Reduced 11.88%	197,300 $2.13 Million
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $159,032 - $263,886	20,600 Added 10.13%	223,900 $2.14 Million
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $953,853 - $1.66 Million	100,300 Added 97.38%	203,300 $2.33 Million
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $445,005 - $649,605	-34,100 Reduced 24.87%	103,000 $1.75 Million
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $1.51 Million - $2.15 Million	-108,555 Reduced 44.19%	137,100 $1.95 Million
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $748,560 - $1.18 Million	-44,824 Reduced 15.43%	245,655 $4.67 Million
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $3.04 Million - $4.54 Million	261,679 Added 908.61%	290,479 $4.76 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $241,920 - $432,000	28,800	28,800 $432,000

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $70.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account